Pacira BioSciences
PCRX
PCRX
208 hedge funds and large institutions have $3.76B invested in Pacira BioSciences in 2014 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 83 increasing their positions, 69 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
18% less call options, than puts
Call options by funds: $21.8M | Put options by funds: $26.7M
Holders
208
Holding in Top 10
9
Calls
$21.8M
Puts
$26.7M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$39.3M | |
| 3 | +$39.1M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$36.7M |
| 5 |
O
OrbiMed
New York
|
+$23.1M |
Top Sellers
| 1 | -$51.5M | |
| 2 | -$40.3M | |
| 3 | -$30.8M | |
| 4 |
Jennison Associates
New York
|
-$26.2M |
| 5 |
Millennium Management
New York
|
-$25.1M |